Catalog #CGL10
Cagrilintide
10 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$110.00
Related Laboratory Supply
Laboratory Research Diluent — 0.9% Benzyl Alcohol is available separately for qualified laboratory workflows. Research use only. Not for human or animal use. Not for injection, diagnostic, clinical, therapeutic, or veterinary use.
View Laboratory Research Diluent →Technical Research Description
Cagrilintide is a long-acting acylated amylin analog designed for once-weekly administration. It activates amylin receptors (AMY1-3) to modulate gastric emptying, suppress glucagon secretion, and influence satiety signaling pathways in metabolic research applications.
Simplified Explanation
Cagrilintide mimics amylin, a hormone released with insulin after meals. It's engineered to last much longer in the body than natural amylin. Researchers study how it helps regulate appetite, slow digestion, and control blood sugar levels.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Customer Reviews
No reviews yet — be the first to share your experience.
From Our Research Blog
Background reading and laboratory context for Cagrilintide 10 MG — sourced from our research articles.
research
Tirzepatide dual receptor mechanism: why it matters
A research-first tour of tirzepatide's GIP/GLP-1 agonism: signaling bias, beta-cell effects, appetite circuits, and experimental d…
Aug 3, 2026
research
"WOLVERINE" BPC-157 + TB-500: Combo Rationale
A research-first look at why pairing BPC-157 and TB-500 shows up in repair biology literature, plus practical readouts for lab stu…
Jul 29, 2026
research
Tirzepatide: A dual incretin tool for metabolic work
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in preclinical metabolic studies. Here's what to measure, control, and compa…
Jul 16, 2026
research
Other Trending Peptides in the Spotlight: What's Next?
A research-first tour of trending peptides-cagrilintide, semax, and others-covering mechanisms, preclinical signals, and lab quest…
Jul 13, 2026
research
Survodutide and the GLP-1/Glucagon Research Split
Survodutide pairs GLP-1 and glucagon receptor agonism in one peptide. Here's what preclinical work suggests, and what to measure n…
Jul 8, 2026
research
CagriSema: what the combo teaches metabolic research
CagriSema pairs an amylin-pathway agonist with a GLP-1 agonist. Here's what preclinical and early studies suggest-and what remains…
Jul 7, 2026